Table of Content

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Diabetes Care Devices Market, by Product
1.4.2 Asia Pacific Diabetes Care Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.2.5 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements : 2018, Oct – 2022, May) Leading Players
Chapter 4. Asia Pacific Diabetes Care Devices Market by Product
4.1 Asia Pacific Insulin Delivery Devices Market by Country
4.2 Asia Pacific Blood Glucose Monitoring Devices Market by Country
Chapter 5. Asia Pacific Diabetes Care Devices Market by Country
5.1 China Diabetes Care Devices Market
5.1.1 China Diabetes Care Devices Market by Product
5.2 Japan Diabetes Care Devices Market
5.2.1 Japan Diabetes Care Devices Market by Product
5.3 India Diabetes Care Devices Market
5.3.1 India Diabetes Care Devices Market by Product
5.4 South Korea Diabetes Care Devices Market
5.4.1 South Korea Diabetes Care Devices Market by Product
5.5 Singapore Diabetes Care Devices Market
5.5.1 Singapore Diabetes Care Devices Market by Product
5.6 Malaysia Diabetes Care Devices Market
5.6.1 Malaysia Diabetes Care Devices Market by Product
5.7 Rest of Asia Pacific Diabetes Care Devices Market
5.7.1 Rest of Asia Pacific Diabetes Care Devices Market by Product
Chapter 6. Company Profiles
6.1 F. Hoffmann-La Roche Ltd.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Partnerships, Collaborations, and Agreements:
6.1.5.2 Product Launches and Product Expansions:
6.2 DexCom, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expenses
6.2.5 Recent strategies and developments:
6.2.5.1 Partnerships, Collaborations, and Agreements:
6.2.5.2 Product Launches and Product Expansions:
6.2.5.3 Acquisition and Mergers:
6.3 Novo Nordisk A/S
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental & Regional Analysis
6.3.4 Research & Development Expenses
6.3.5 Recent strategies and developments:
6.3.5.1 Partnerships, Collaborations, and Agreements:
6.3.5.2 Acquisition and Mergers:
6.4 Sanofi S.A.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.4.5 Recent strategies and developments:
6.4.5.1 Partnerships, Collaborations, and Agreements:
6.4.5.2 Product Launches and Product Expansions:
6.5 Zealand Pharma A/S (Valeritas, Inc.)
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Research & Development Expenses
6.5.4 Recent strategies and developments:
6.5.4.1 Product Launches and Product Expansions:
6.5.4.2 Approvals and Trials:
6.6 B. Braun Melsungen AG
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expenses
6.6.5 Recent strategies and developments:
6.6.5.1 Partnerships, Collaborations, and Agreements:
6.7 Bayer AG
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expense
6.7.5 Recent strategies and developments:
6.7.5.1 Partnerships, Collaborations, and Agreements:
6.7.5.2 Approvals:
6.8 Abbott Laboratories
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expense
6.8.5 Recent strategies and developments:
6.8.5.1 Partnerships, Collaborations, and Agreements:
6.8.5.2 Approvals:
6.9 Ypsomed AG
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Recent strategies and developments:
6.9.4.1 Partnerships, Collaborations, and Agreements:
6.10. Arkray, Inc.
6.10.1 Company Overview
6.10.2 Recent strategies and developments:
6.10.2.1 Partnerships, Collaborations, and Agreements:
6.10.2.2 Geographical Expansions:



List of Tables

TABLE 1 Asia Pacific Diabetes Care Devices Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Diabetes Care Devices Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Diabetes Care Devices Market
TABLE 4 Product Launches And Product Expansions– Diabetes Care Devices Market
TABLE 5 Acquisition and Mergers– Diabetes Care Devices Market
TABLE 6 Geographical expansion– Diabetes Care Devices Market
TABLE 7 Approvals and Trials– Diabetes Care Devices Market
TABLE 8 Asia Pacific Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
TABLE 9 Asia Pacific Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
TABLE 10 Asia Pacific Insulin Delivery Devices Market by Country, 2018 - 2021, USD Million
TABLE 11 Asia Pacific Insulin Delivery Devices Market by Country, 2022 - 2028, USD Million
TABLE 12 Asia Pacific Blood Glucose Monitoring Devices Market by Country, 2018 - 2021, USD Million
TABLE 13 Asia Pacific Blood Glucose Monitoring Devices Market by Country, 2022 - 2028, USD Million
TABLE 14 Asia Pacific Diabetes Care Devices Market by Country, 2018 - 2021, USD Million
TABLE 15 Asia Pacific Diabetes Care Devices Market by Country, 2022 - 2028, USD Million
TABLE 16 China Diabetes Care Devices Market, 2018 - 2021, USD Million
TABLE 17 China Diabetes Care Devices Market, 2022 - 2028, USD Million
TABLE 18 China Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
TABLE 19 China Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
TABLE 20 Japan Diabetes Care Devices Market, 2018 - 2021, USD Million
TABLE 21 Japan Diabetes Care Devices Market, 2022 - 2028, USD Million
TABLE 22 Japan Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
TABLE 23 Japan Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
TABLE 24 India Diabetes Care Devices Market, 2018 - 2021, USD Million
TABLE 25 India Diabetes Care Devices Market, 2022 - 2028, USD Million
TABLE 26 India Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
TABLE 27 India Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
TABLE 28 South Korea Diabetes Care Devices Market, 2018 - 2021, USD Million
TABLE 29 South Korea Diabetes Care Devices Market, 2022 - 2028, USD Million
TABLE 30 South Korea Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
TABLE 31 South Korea Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
TABLE 32 Singapore Diabetes Care Devices Market, 2018 - 2021, USD Million
TABLE 33 Singapore Diabetes Care Devices Market, 2022 - 2028, USD Million
TABLE 34 Singapore Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
TABLE 35 Singapore Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
TABLE 36 Malaysia Diabetes Care Devices Market, 2018 - 2021, USD Million
TABLE 37 Malaysia Diabetes Care Devices Market, 2022 - 2028, USD Million
TABLE 38 Malaysia Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
TABLE 39 Malaysia Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
TABLE 40 Rest of Asia Pacific Diabetes Care Devices Market, 2018 - 2021, USD Million
TABLE 41 Rest of Asia Pacific Diabetes Care Devices Market, 2022 - 2028, USD Million
TABLE 42 Rest of Asia Pacific Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
TABLE 43 Rest of Asia Pacific Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
TABLE 44 KEY INFORMATION – F. HOFFMANN-LA ROCHE LTD.
TABLE 45 Key Information – DexCom, Inc.
TABLE 46 Key information – Novo Nordisk A/S
TABLE 47 Key Information – Sanofi S.A.
TABLE 48 Key Information – Zealand Pharma A/S
TABLE 49 key Information – B. Braun Melsungen AG
TABLE 50 Key Information – Bayer AG
TABLE 51 Key Information – Abbott Laboratories
TABLE 52 Key Information –-Ypsomed AG
TABLE 53 Key Information – Arkray, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Partnerships, collaborations and agreements : 2018, oct – 2022, may) Leading Players
FIG 5 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
FIG 6 Recent strategies and developments: DexCom, Inc.
FIG 7 Recent strategies and developments: Novo Nordisk A/S
FIG 8 Recent strategies and developments: Sanofi S.A.
FIG 9 Recent strategies and developments: Zealand Pharma A/S
FIG 10 Recent strategies and developments: Arkray, Inc.